Licensed provider review·support@lumoramd.com·Log in
← Medications
MedicationGrowth Hormone Support

CJC-1295 / Ipamorelin.

A paired GHRH and ghrelin-receptor combination for natural, pulsatile growth hormone release.

1.2 mg / 2 mg per mL · single-vial subcutaneous injectable

Pricing is shown after your free assessment, before you commit.

Start provider review →

Free to start. No card required.

Is this for you?

This is for you if

  • Adults with age-related decline in IGF-1 or signs of GH-axis slowdown
  • Patients wanting recovery, sleep, and body-composition support in one protocol
  • Patients who want to preserve natural GH rhythm rather than replace hormones
  • Patients pursuing collagen, skin, and connective-tissue support

This isn't for you if

Not appropriate during pregnancy, breastfeeding, or with active malignancy. May affect glucose regulation — baseline IGF-1, glucose, and HbA1c are recommended. Components are dispensed through 503A compounding pharmacies under physician oversight.

What it is

CJC-1295 / Ipamorelin

This combination pairs CJC-1295 — a long-acting GHRH analog — with Ipamorelin, a selective ghrelin-receptor peptide. The two are formulated in one vial so a single nightly injection restores the body's natural pulse of growth hormone, rather than overriding it with synthetic HGH.

How it works

Mechanism and fit.

CJC-1295 sustains the upstream signal that tells the pituitary to release growth hormone. Ipamorelin layers a clean pulse on top of that signal — without the cortisol or hunger spikes that older GH-axis compounds caused. The combined effect is a youthful, physiologic GH pattern that supports recovery, sleep depth, collagen production, and metabolic resilience.

When it may fit

Who this is typically for.

  • Adults with age-related decline in IGF-1 or signs of GH-axis slowdown
  • Patients wanting recovery, sleep, and body-composition support in one protocol
  • Patients who want to preserve natural GH rhythm rather than replace hormones
  • Patients pursuing collagen, skin, and connective-tissue support
CJC-1295 / Ipamorelin - common questions

What patients
most often ask.

Why combine these two peptides?+

Each works on a different mechanism — CJC-1295 sustains the GH-release signal, Ipamorelin triggers clean GH pulses. Together they produce a steadier, more physiologic GH response than either does alone, while keeping cortisol and appetite undisturbed.

Is this the same as HGH?+

No. This combination signals your own pituitary to release growth hormone in its natural pulse pattern. It works with your endocrine system, not around it.

When it may fit

Who this is typically for.

These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.

  • <ul><li>Adults with age-related decline in IGF-1 or signs of GH-axis slowdown</li><li>Patients wanting recovery, sleep, and body-composition support in one protocol</li><li>Patients who want to preserve natural GH rhythm rather than replace hormones</li><li>Patients pursuing collagen, skin, and connective-tissue support</li></ul>
Provider plan

How this option
is evaluated.

The plan is provider-determined after reviewing your assessment and safety factors.

  • DosingOnce nightly subcutaneously, typically 5 nights on / 2 nights off, 30–60 minutes before bed.
  • Typical durationInitial cycle 8–12 weeks; many patients continue 3–6 months under provider guidance.
  • Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
How care works
  • A licensed provider reviews your assessment before any treatment is recommended.
  • You see full pricing - visit fees, medication, labs, follow-up - before you commit.
  • Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
  • Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.

Start with
provider review.

If you are considering CJC-1295 / Ipamorelin, the first step is a free assessment. A provider determines whether it fits your goals and medical history.

Start provider review →

A provider determines whether treatment is clinically appropriate.

Important information
Lumora may prescribe FDA-approved or compounded medications when clinically appropriate. Compounded medications are not approved by the FDA and are dispensed by a licensed pharmacy under the supervision of a licensed provider.